Solara Active Pharma: Carving Out Ibuprofen to Recapture Margin
Solara's Q1 FY27 net profit up 55% YoY to INR 16.3 crore, debt reduced, considering sale of loss-making Ibuprofen business, potential for margin...
177 Views
Solara Active Pharma: From Debt Overhang to Operational Reset
Solara's Q4 FY26 saw record revenue, gross margin, and EBITDA driven by base business growth, with potential for even higher margins once...
140 Views
Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026
Solara is a pure-play Active Pharmaceutical Ingredients (API) manufacturer emerging from a significant operational and financial reset, showing...
122 Views
Prices Drop, Eyes Pop: Mid-Month Insider Buying Activity Update – Part 3
Insider buying activity in mid and small-cap Indian listed stocks has increased, with 50 companies reporting transactions this week.
508 Views
Prices Drop, Eyes Pop: Mid-Month Insider Buying Activity Update – Part 2
Insider buying activity in Indian mid and small-cap stocks has increased due to steep decline in equity market, prompting a mid-month update.
548 Views